Blog

Finally, Some Good News for GameStop

Four months ago, I said that I wouldn't touch GameStop (NYSE: GME) stock with a 10-foot Energy Sword before the company makes some radical changes to its business model. Since then, GameStop has

TheMotleyFool

0

As This Industry Transforms, One Company Is Making Shareholders Rich

As the COVID-19 vaccine race unfolded and it became clear that vaccine candidates that use messenger RNA (mRNA) were at the forefront, concerns over the technology ranged from the reasonable to the

TheMotleyFool

0

3 Great Reasons to Buy NVIDIA Stock

Even in the face of the pandemic, NVIDIA (NASDAQ: NVDA) was a clear winner, notching gains of 122% in 2020. The company's graphics processing units (GPUs) were front and center for many of the

TheMotleyFool

0

Saving for Retirement Is Getting Harder. Here's What to Do About It.

No, you're not imagining it. Your parents' and grandparents' generations had it a lot easier when it comes to retirement savings. Over the years, new obstacles have cropped up that have made saving

TheMotleyFool

0

3 Biotech Stocks That Could Be Millionaire-Makers

Biotech companies are about the riskiest investment someone can find in the stock market. They are often small, cash-strapped, and have a future inextricably tied to the success or failure of one

TheMotleyFool

0

2 Great Healthcare Stocks to Buy on Sale Right Now

Investing over the past year has been challenging. Underlying the early 2020 stock market collapse and its subsequent run-up to new all-time highs, there was a shift toward companies that

TheMotleyFool

0

Could Cresco Labs Be a Millionaire-Maker Stock?

Cresco Labs (CNSX: CL)(OTC: CRLBF) has been flying high over the past year. Through the last 12 months, shares of the No. 1 cannabis wholesaler in the country are up a whopping 180%. Despite its

TheMotleyFool

0

3 Dividend Stocks That Pay You More Than Pepsi Does

PepsiCo (NASDAQ: PEP) is a great dividend stock. With a yield of 2.8%, the stock earns you well above the S&P 500 average of just 1.5%. And on a $25,000 investment, the stock could generate $700 in

TheMotleyFool

0

Why Shrinking Auto Inventories Are No Problem for Ally Bank

The coronavirus pandemic and related shutdowns have had far-reaching impacts. Not only has it affected us on a personal level, but businesses have seen disruptions in their supply chains -- throwing

TheMotleyFool

0

This Cannabis Company Just Took a Massive Step Toward the Mainstream

Buzzworthy news that can lead to more investing exposure is exciting for under-the-radar companies. On April 20 -- which just happens to be known as an unofficial marijuana holiday -- Auxly Cannabis

TheMotleyFool

0

5 Surefire Dividend Stocks You Can Buy Right Now

The vast majority of retirement portfolios have one thing in common: They're powered by great dividend stocks.

Although most dividend stocks are "boring," that's not a bad thing. Regularly doling

TheMotleyFool

0

How Illumina's Q1 Results Delighted Investors

Investors already pretty much knew what to expect on the top line in Illumina's (NASDAQ: ILMN) first-quarter results. The genomic sequencing systems leader provided a sneak peek at its Q1 revenue a

TheMotleyFool

0

Ready for Social Security? Not Till You Can Answer These 3 Questions.

Millions of seniors today rely on Social Security to pay the bills -- and you may think the time has come for you to join their ranks. But before you go out and file for benefits, make sure you can

TheMotleyFool

0

Why Amgen's Q1 Results Disappointed Investors

Amgen (NASDAQ: AMGN) has taken investors on a roller coaster ride over the last 12 months. The stock has experienced multiple swings -- up and down -- of 10% or more. And now it looks like another

TheMotleyFool

0

Here's the Biggest Risk With Buying Ocugen Stock Right Now

Ocugen (NASDAQ: OCGN) practically came out of nowhere to become a huge winner. Its shares are up more than 500% year to date. The biotech quickly vaulted into the top 100 most popular stocks among

TheMotleyFool

0

Buy Alert: Regeneron Stock Is Headed Higher

Regeneron Pharmaceuticals (NASDAQ: REGN) is one of the few companies selling a treatment for COVID-19. The U.S. Food and Drug Administration (FDA) authorized its antibody cocktail in November

TheMotleyFool

0

Can Inovio Recover From Its Huge Setback?

Inovio Pharmaceuticals (NASDAQ: INO) hasn't ranked among the leaders in the COVID-19 vaccine race so far. However, the small biotech has been a definite contender in the second tier of vaccine

TheMotleyFool

0

5 Ultra-Popular Growth Stocks With 28% to 56% Upside, According to Wall Street

For 13 months, Wall Street has proved virtually unstoppable. Since hitting a bear market bottom on March 23, 2020, the broad-based S&P 500 has galloped higher by 87%, through this past weekend. This

TheMotleyFool

0

Investing in These Stocks Now Could Make You a Millionaire Retiree

It's much better to be a millionaire retiree than a thousandaire one. You're probably not going to become one, though, unless you take some steps toward it. One good way is to regularly invest

TheMotleyFool

0

Retiring Within 5 Years? Do These Things Now

Retirement is an exciting milestone to look forward to, and if you're within five years of it, you may already have your own little countdown going. But before you leave the workforce for good, make

TheMotleyFool

0